The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for zanubrutinib (BeiGene AUS Pty Ltd)
Active ingredients
zanubrutinib
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Therapeutic area
Haematology